PCD Pharma Franchise Opportunities in Nagaland with Daksh Diabetes and Cardiac Care
Recent health data reveals that lifestyle diseases, particularly diabetes and hypertension, are emerging as significant health challenges in Nagaland. The Chakhesang Naga tribe, one of the prominent communities in the state, has a hypertension prevalence of 36% and a diabetes prevalence of 18%, rates significantly higher than broader regional and national averages. A separate study among adults aged 25-64 in Mokokchung district found a hypertension prevalence of 43.2%. Hypertension is a leading cause of morbidity in the state, with 12,244 recorded cases and an incidence of 4.55 per 1,000 population.
The primary drivers include lifestyle factors such as smokeless tobacco use (58.9% males, 49.6% females), current smoking (38.1% males), inadequate fruit and vegetable intake (80.1% males, 93.6% females), and alcohol consumption . Among Ao Nagas, urban dwellers show significantly higher rates of low physical activity, overweight/obesity, and clustering of multiple risk factors compared to rural populations, while villagers are more likely to be hypertensive. The state’s unique dietary habits, including smoked meat and fermented products, further contribute to the disease burden.
The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Nagaland families to take control of their health through regular screening, medication adherence, lifestyle modifications, and early detection ensuring that every 10th person does not become a statistic but a success story of integrated care and better health outcomes.
How Daksh is making a Difference in Nagaland
1. Affordable, Quality-Assured Medications
Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment.
What this means for Nagaland patients:
- Access to WHO-GMP certified medications
- Lower out-of-pocket expenses for lifelong treatments
- No compromise on quality despite affordable pricing
2. Complete Cardiac Care Portfolio
Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs:
| Product Category | Daksh Offerings | Purpose |
| ACE Inhibitors | DORAPIL (Ramipril) | Blood pressure control, heart failure treatment |
| ARBs | CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) | Hypertension management |
| Beta-Blockers | CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) | Heart rate control, heart failure |
| Calcium Channel Blockers | DUPIN (Amlodipine), CLINITAC (Cilnidipine) | Blood pressure, angina |
| Diuretics | TORDAC (Torsemide), FRUSIDIP | Fluid management in heart failure |
| Lipid Management | ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) | Cholesterol control |
3. Complete Diabetic Care Portfolio
For diabetes management, Daksh provides modern therapeutic options including:
| Product Category | Daksh Offerings |
| SGLT2 Inhibitors | DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug |
| DPP-4 Inhibitors | TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) |
| Sulfonylureas | GLIMIDAC (Glimepiride) |
| Biguanides | GLYCODIP SR (Metformin) |
| Combination Therapies | DYFOZIN M, GLIMIDAC MV (triple combination) |
4. Focus on Preventive Care
Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications:
- Liver tonics for medication-induced liver protection
- Calcium supplements for bone health (critical for diabetic patients)
- Vitamin complexes for overall metabolic support
5. Supporting Healthcare Providers across Nagaland
Daksh works with hospitals, clinics, and pharmacies across Nagaland to ensure that quality medications reach every corner of the state. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses.
With the state’s high disease burden and growing pharmaceutical sector, there is immense potential to build a meaningful healthcare business while serving your community.
Popular Locations for PCD Pharma Franchise in Nagaland
| PCD / Franchise Keywords | Product / Therapy Keywords |
| PCD pharma franchise in Kohima | Cardiac diabetic PCD company in Kohima |
| PCD pharma franchise in Dimapur | Cardiac diabetic products in Dimapur |
| PCD pharma franchise in Mokokchung | Diabetic cardiac PCD franchise in Mokokchung |
| PCD pharma franchise in Tuensang | Cardiac diabetic PCD company in Tuensang |
| PCD pharma franchise in Wokha | Cardiac diabetic products in Wokha |
| PCD pharma franchise in Zunheboto | Diabetic cardiac PCD franchise in Zunheboto |
| PCD pharma franchise in Phek | Cardiac diabetic PCD company in Phek |
| PCD pharma franchise in Mon | Cardiac diabetic products in Mon |
| PCD pharma franchise in Longleng | Diabetic cardiac PCD franchise in Longleng |
| PCD pharma franchise in Kiphire | Cardiac diabetic PCD company in Kiphire |
Conclusion
The diabetes and heart disease burden in Nagaland is not just a statistic—it is a reality affecting thousands of families. With a hypertension prevalence of 36%–43% in tribal populations, a diabetes prevalence of 18% among the Chakhesang tribe, and high rates of tobacco use and poor dietary habits, the burden is already immense and growing. But there is hope. With the right medications, proper awareness, and accessible healthcare, patients can live long, healthy, and fulfilling lives.
Daksh Diabetic & Cardiac Care is committed to being part of this solution—providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines.
Contact Daksh Diabetic and Cardiac
| Contact Method | Details |
| Office Address | Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India |
| Phone | 📞 +91 93565 60523 📞 +91 78886 02869 |
| enquirypurchase.daksh@gmail.com | |
| Contact us | https://diabetes-cardiac.com/contact-us/ |